Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 4,100.00
-245.00 (-5.64%)
Oct 12, 2026, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 95.36 billion as of October 12, 2026. It is the 27,685th most valuable company in the world and the 1,343rd biggest in South Korea. Its market cap has decreased by 54.60% in one year.
Market Cap
95.36B
Enterprise Value
57.31B
Revenue
n/a
Global Rank
Country Rank
#1,343 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has decreased from 160.24B to 95.36B, a decrease of -40.49%. That is a compound annual growth rate of -8.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 95.36B | -58.96% |
| Dec 30, 2025 | 232.34B | -3.12% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 208.59B |
| NeoImmuneTech | 187.06B |
| Anterogen.Co.,Ltd. | 162.00B |
| Genexine | 132.12B |
| MedPacto | 102.31B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 71.63B |
| Amicogen | 69.47B |